| 
Results for antisense. Search took 0.14 seconds.
Symposium: Regulatory RNA in Biology and Human Health
in The Biotech Weblog, on August 28, 2007
...group of researchers working in RNA interference, X-chromosome inactivation and naturally occurring antisense transcripts will look at our current understanding of the mechanisms of action and biogene...
First Antisense Drug for Chemotherapy-Responsive Chronic Lymphocytic Leukemia
in The Biotech Weblog, on February 19, 2007
...
A phase III clinical trial for oblimersen (trade name: Genasense ), the first "antisense" drug to be tested in chronic lymphocytic leukemia (CLL), shows promise as an adjunct therap...
More than 400 Biotechnology Drugs and Vaccines Under Trials
in The Biotech Weblog, on August 16, 2006
...s targeting asthma, lupus and various types of cancer
vaccines designed against AIDS and cancer
antisense products as potential treatments for cancer and heart disease
gene therapy testing in ca...
Second Annual Meeting of the Oligonucleotide Therapeutics Society
in The Biotech Weblog, on June 27, 2006
...linical and clinical research for oligonucleotide-based therapeutics such as RNAi, Aptamers, Antisense, and immunostimulatory compounds such as CpG.
Special sessions will be devoted to:
Oli...
RNAi and Antisense RNA Therapy from the Tangled Bank
in The Biotech Weblog, on June 19, 2006
...this blog, and both can be found at Fight Aging :
RNA Interference as the New Gene Therapy
Antisense RNA Therapies
Both articles provide a short introduction into this novel technology i...
ISIS 301012 Shows Favorable Phase 2 Clinical Trial Results Against Atherosclerosis
in The Biotech Weblog, on May 2, 2006
...es triglycerides , an additional risk factor for coronary artery disease."
ISIS 301012 is an antisense drug that inhibits the expression of a protein called apoB-100 , which has been shown to...